113 related articles for article (PubMed ID: 9226848)
21. The presence of cross-reactive antibodies to rabbit haemorrhagic disease virus in Australian wild rabbits prior to the escape of virus from quarantine.
Nagesha HS; McColl KA; Collins BJ; Morrissy CJ; Wang LF; Westbury HA
Arch Virol; 2000; 145(4):749-57. PubMed ID: 10893153
[TBL] [Abstract][Full Text] [Related]
22. Presence of rabbit haemorrhagic disease virus antigen in rabbit tissues as revealed by a monoclonal antibody dependent capture ELISA.
Collins BJ; White JR; Lenghaus C; Morrissy CJ; Westbury HA
J Virol Methods; 1996 Apr; 58(1-2):145-54. PubMed ID: 8783160
[TBL] [Abstract][Full Text] [Related]
23. Comparative analysis of rabbit hemorrhagic disease virus (RHDV) and new RHDV2 virus antigenicity, using specific virus-like particles.
Bárcena J; Guerra B; Angulo I; González J; Valcárcel F; Mata CP; Castón JR; Blanco E; Alejo A
Vet Res; 2015 Sep; 46(1):106. PubMed ID: 26403184
[TBL] [Abstract][Full Text] [Related]
24. Rabbit haemorrhagic disease: advantages of cELISA in assessing immunity in wild rabbits (Oryctolagus cuniculus).
Zheng T; Parkes JP
Vet Microbiol; 2011 Dec; 153(3-4):387-92. PubMed ID: 21719216
[TBL] [Abstract][Full Text] [Related]
25. Detection of antibodies to rabbit haemorrhagic disease virus: an immunoblotting method using virus-coated human erythrocyte membranes.
Ruvoen-Clouet N; Blanchard D; Andre-Fontaine G; Song B; Ganiere JP
Zentralbl Veterinarmed B; 1995 Jun; 42(4):197-204. PubMed ID: 8546017
[TBL] [Abstract][Full Text] [Related]
26. Susceptibility of hares and rabbits to the European brown hare syndrome virus (EBHSV) and rabbit haemorrhagic disease virus (RHDV) under experimental conditions.
Lavazza A; Scicluna MT; Capucci L
Zentralbl Veterinarmed B; 1996 Sep; 43(7):401-10. PubMed ID: 8885705
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of a commercial vaccine against different strains of rabbit haemorrhagic disease virus.
Read AJ; Kirkland PD
Aust Vet J; 2017 Jul; 95(7):223-226. PubMed ID: 28653381
[TBL] [Abstract][Full Text] [Related]
28. Identification of two novel rabbit hemorrhagic disease virus (RHDV) B cell epitopes and evaluation of its immunoprotection against RHDV.
DeSheng K; HuaiRan L; JiaSen L; Zuo Y; Qian J; DongChun G; XiaoLiang H; FengJie W; QianQian H; LianDong Q
Appl Microbiol Biotechnol; 2015 Jul; 99(14):5951-66. PubMed ID: 25895085
[TBL] [Abstract][Full Text] [Related]
29. Serologic comparison of four isolates of rabbit hemorrhagic disease virus.
Berninger ML; House C
Vet Microbiol; 1995 Nov; 47(1-2):157-65. PubMed ID: 8604547
[TBL] [Abstract][Full Text] [Related]
30. Rabbit haemorrhagic disease: Cross-protection and comparative pathogenicity of GI.2/RHDV2/b and GI.1b/RHDV lagoviruses in a challenge trial.
Calvete C; Mendoza M; Alcaraz A; Sarto MP; Jiménez-de-Bagüéss MP; Calvo AJ; Monroy F; Calvo JH
Vet Microbiol; 2018 Jun; 219():87-95. PubMed ID: 29778210
[TBL] [Abstract][Full Text] [Related]
31. Novel bivalent vectored vaccine for control of myxomatosis and rabbit haemorrhagic disease.
Spibey N; McCabe VJ; Greenwood NM; Jack SC; Sutton D; van der Waart L
Vet Rec; 2012 Mar; 170(12):309. PubMed ID: 22266680
[TBL] [Abstract][Full Text] [Related]
32. Self-assembly of virus-like particles of rabbit hemorrhagic disease virus capsid protein expressed in Escherichia coli and their immunogenicity in rabbits.
Guo H; Zhu J; Tan Y; Li C; Chen Z; Sun S; Liu G
Antiviral Res; 2016 Jul; 131():85-91. PubMed ID: 27118636
[TBL] [Abstract][Full Text] [Related]
33. Use of ELISAs in field studies of rabbit haemorrhagic disease (RHD) in Australia.
Cooke BD; Robinson AJ; Merchant JC; Nardin A; Capucci L
Epidemiol Infect; 2000 Jun; 124(3):563-76. PubMed ID: 10982081
[TBL] [Abstract][Full Text] [Related]
34. Persistence of rabbit haemorrhagic disease virus genome in vaccinated rabbits after experimental infection.
Gall A; Schirrmeier H
J Vet Med B Infect Dis Vet Public Health; 2006 Oct; 53(8):358-62. PubMed ID: 17010038
[TBL] [Abstract][Full Text] [Related]
35. Benign circulation of rabbit haemorrhagic disease virus on Lambay Island, Eire.
Forrester NL; Trout RC; Gould EA
Virology; 2007 Feb; 358(1):18-22. PubMed ID: 17049958
[TBL] [Abstract][Full Text] [Related]
36. Possible interaction between myxomatosis and calicivirosis related to rabbit haemorrhagic disease affecting the European rabbit.
Marchandeau S; Bertagnoli S; Peralta B; Boucraut-Baralon C; Letty J; Reitz F
Vet Rec; 2004 Nov; 155(19):589-92. PubMed ID: 15573951
[TBL] [Abstract][Full Text] [Related]
37. A new recombinant Orf virus (ORFV, Parapoxvirus) protects rabbits against lethal infection with rabbit hemorrhagic disease virus (RHDV).
Rohde J; Schirrmeier H; Granzow H; Rziha HJ
Vaccine; 2011 Nov; 29(49):9256-64. PubMed ID: 22001119
[TBL] [Abstract][Full Text] [Related]
38. A serial cross-sectional study of the prevalence of rabbit haemorrhagic disease on three farms in the lower North Island of New Zealand.
Henning J; Davies P
N Z Vet J; 2005 Apr; 53(2):149-53. PubMed ID: 15846400
[TBL] [Abstract][Full Text] [Related]
39. Survival of rabbit haemorrhagic disease virus (RHDV) in the environment.
Henning J; Meers J; Davies PR; Morris RS
Epidemiol Infect; 2005 Aug; 133(4):719-30. PubMed ID: 16050519
[TBL] [Abstract][Full Text] [Related]
40. The Taishan Robinia pseudoacacia polysaccharides enhance immune effects of rabbit haemorrhagic disease virus inactivated vaccines.
Yang S; Li G; Zhao Z; Feng M; Fu J; Huang Z; Song M; Lin S
Microb Pathog; 2017 Nov; 112():70-75. PubMed ID: 28935204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
